Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.7879
-0.0548 (-6.50%)
At close: Apr 25, 2025, 4:00 PM
0.7965
+0.0086 (1.09%)
After-hours: Apr 25, 2025, 6:49 PM EDT
Plus Therapeutics Market Cap
Plus Therapeutics has a market cap or net worth of $13.39 million as of April 25, 2025. Its market cap has increased by 67.43% in one year.
Market Cap
13.39M
Enterprise Value
13.16M
1-Year Change
67.43%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since November 16, 2000, Plus Therapeutics's market cap has decreased from $177.00M to $13.39M, a decrease of -92.43%. That is a compound annual growth rate of -10.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2025 | 13.40M | 97.06% |
Dec 31, 2024 | 6.80M | -13.92% |
Dec 29, 2023 | 7.90M | -26.17% |
Dec 30, 2022 | 10.70M | -33.54% |
Dec 31, 2021 | 16.10M | 65.98% |
Dec 31, 2020 | 9.70M | 7.78% |
Dec 31, 2019 | 9.00M | 136.84% |
Dec 31, 2018 | 3.80M | -64.15% |
Dec 29, 2017 | 10.60M | -65.81% |
Dec 30, 2016 | 31.00M | 5.80% |
Dec 31, 2015 | 29.30M | -35.18% |
Dec 31, 2014 | 45.20M | -73.87% |
Dec 31, 2013 | 173.00M | 5.10% |
Dec 31, 2012 | 164.60M | 35.36% |
Dec 30, 2011 | 121.60M | -53.57% |
Dec 31, 2010 | 261.90M | 10.74% |
Dec 31, 2009 | 236.50M | 124.17% |
Dec 31, 2008 | 105.50M | -27.49% |
Dec 31, 2007 | 145.50M | 18.58% |
Dec 29, 2006 | 122.70M | -3.31% |
Dec 30, 2005 | 126.90M | 231.33% |
Dec 31, 2004 | 38.30M | -14.70% |
Dec 31, 2003 | 44.90M | -13.82% |
Dec 31, 2002 | 52.10M | 8.09% |
Dec 31, 2001 | 48.20M | -72.77% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 744.81B |
UnitedHealth Group | 389.54B |
Johnson & Johnson | 374.44B |
AbbVie | 313.20B |
Novo Nordisk | 276.62B |
Abbott Laboratories | 225.18B |
AstraZeneca | 213.42B |
Novartis AG | 208.99B |